Build your career on Magnet.me
Create a profile and receive smart job recommendations based on your liked jobs.
Reageer t/m 12 mei
Join a translational AI-oncology project that uses atlas-scale bulk, single-cell and spatial transcriptomic data to generate synthetic transcriptomes as realistic as possible and improve predictive models of cancer response.
In this internship you will contribute to a computational proof-of-concept that improves predictive model performance by using additional synthetic transcriptomes.
Your activities may include:
You will work within UMCG on a multidisciplinary project at the intersection of medical oncology, computational immunology, spatial transcriptomics and AI. The project builds on unique harmonised datasets from endometrial cancer, including bulk, single-cell and spatial transcriptomic profiles, and is embedded in a network spanning oncology, pathology, molecular biology and biomedical AI.
Not all cancer patients respond to the immunotherapy treatments. Predictive models do not perform well due to low sample size in rare cancers. Can generating realistic synthetic transcriptomes help improve the performance of the predictive models?
You are a MSc or advanced BSc student in bioinformatics, computational biology, AI, data science, biomedical sciences, mathematics or a related field.
Good to know: in consultation, part of the internship can be performed from home.
Het Universitair Medisch Centrum Groningen (UMCG) is één van de grootste ziekenhuizen in Nederland en is de grootste werkgever van Noord-Nederland. De ruim 12.000 medewerkers werken samen aan zorg, onderzoek, opleiding en onderwijs met als gemeenschappelijke doelstelling: bouwen aan de toekomst van gezondheid.
Deze bedrijfspagina is automatisch gegenereerd en bevat daarom nog weinig informatie. Je vindt meer informatie over ‘bedrijfsnaam’ op hun website: ‘’Carrierewebsite’’
View what's on offer:
Change language to: Dutch
This page is optimised for people from the Netherlands. View the version optimised for people from the UK.